Showing results (171-180 of 195) with videos related to
Sort By:
Pageof 20
Human Vaccines & Immunotherapeutics|November 14, 2024
Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimizationKanta Hori, Shuhei Yamada, Kenji Murata, et al.Journal of Neuro-Oncology|July 13, 2024
Genome-wide association study on meningioma risk in Japan: a multicenter prospective studyShuhei Yamada, Toru Umehara, Kyuto Sonehara, et al.Research Square|July 29, 2026
Discovery of a Functional Sequon for Chondroitin Sulfate GlycosylationKenji Uchimura, Yoshiko Takeda-Uchimura, Mayumi Ishihara-Aoki, et al.Scientific Reports|July 4, 2018
Saturated fatty acid attenuates anti-obesity effect of green teaShuya Yamashita, Asami Hirashima, I-Chian Lin, et al.Human Mutation|September 8, 2016
Chondroitin Sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1) Deficiency Results in a Mild Skeletal Dysplasia and Joint LaxityJulia Vodopiutz, Shuji Mizumoto, Ekkehart Lausch, et al.Genes & Development|February 10, 2007
Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular developmentAlexandra Abramsson, Sindhulakshmi Kurup, Marta Busse, et al.ACS Omega|July 20, 2018
Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast CancerAnusha Sebastian, Vijay Pandey, Chakrabhavi Dhananjaya Mohan, et al.Biochemical and Biophysical Research Communications|April 2, 2009
Important role of heparan sulfate in postnatal islet growth and insulin secretionIwao Takahashi, Naoya Noguchi, Koji Nata, et al.Journal of Medical Genetics|January 29, 2020
Pseudodiastrophic dysplasia expands the known phenotypic spectrum of defects in proteoglycan biosynthesisAlicia B Byrne, Shuji Mizumoto, Peer Arts, et al.Cancer Immunology, Immunotherapy : CII|February 16, 2023
Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinomaShuhei Yamada, Haruka Miyata, Makoto Isono, et al.Pageof 20